Steady-state population pharmacokinetics of sustained release theophylline in adult asthmatic patients (Q41147463)

27 September 2017

title

Steady-state population pharmacokinetics of sustained release theophylline in adult asthmatic patients (English)

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

21 November 2022

0 references

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

21 November 2022

author name string

G. Thomas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778539

21 November 2022

R. Koen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778539

21 November 2022

P. Houze

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778539

21 November 2022

G. Lagier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778539

21 November 2022

P. Gervais

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1778539

21 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1778539

21 November 2022

publication date

1 January 1991

1 reference

full work available at URL

27 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1472-8206.1991.tb00750.x

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1472-8206.1991.tb00750.x/fullpdf

21 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Fundamental and Clinical Pharmacology

21 November 2022

published in

1 reference

27 September 2017

volume

5

1 reference

27 September 2017

issue

7

1 reference

27 September 2017

page(s)

611-619

1 reference

Theophylline pharmacokinetics in advanced age

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1991.TB00750.X

Influence of chronic dosing on theophylline clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1991.TB00750.X

Effects of tobacco smoking and oral contraceptive use on theophylline disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1991.TB00750.X

Theophylline A “State of the Art” Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1991.TB00750.X

Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1991.TB00750.X

Theophylline-terbutaline, a steady state study on possible pharmacokinetic interactions with special reference to chronopharmacokinetic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1991.TB00750.X

Theophylline metabolism: Variation and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.1991.TB00750.X

Influence of Age on Theophylline Clearance in Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models

21 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

The simultaneous determination of theophylline, theobromine and caffeine in plasma by high performance liquid chromatography

21 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Cigarette smoking and theophyiiine clearance and metabolism

21 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline Products

21 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

The relationship between clearance of theophylline and age within the adult age range

21 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Effect of disease states on theophylline elimination

21 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Decreased theophylline half-life in cigarette smokers

21 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Therapeutic consequences of drug interactions with theophylline pharmacokinetics

21 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol

21 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Dose-dependent Elimination Kinetics of Theophylline

21 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Dose-dependent kinetics of theophylline

21 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Computational problems of compartment models with michaelis-menten-type elimination

21 November 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Influence of methylxanthine-containing foods on theophylline metabolism and kinetics

21 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man

21 November 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

The population pharmacokinetics of theophylline in neonates and young infants

21 November 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Clinical Pharmacokinetics of Theophylline

21 November 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

The influence of cigarette smoking and sex on theophylline disposition

21 November 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals

21 November 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data

21 November 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

21 November 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Nonlinear theophylline elimination

21 November 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Theophylline pharmacokinetics in patients from a geriatric hospital: influence of cigarette smoking

21 November 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications

21 November 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

Current concepts. Slow-release theophylline rationale and basis for product selection

21 November 2022

40

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.1991.TB00750.X

21 November 2022

Identifiers

1 reference

27 September 2017

1 reference